Allergy skin test responses during experimental infection with respiratory syncytial virus

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 6, 2006, Pages 834-839

  Skoner, David P ^a   Gentile, Deborah A ^a   Angelini, Betty ^a   Doyle, William J ^b  

^a ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HISTAMINE; IMMUNOGLOBULIN G;

ADULT; ALLERGIC DISEASE; ALLERGY TEST; ARTICLE; ASTHMA; BRONCHIOLITIS; CLINICAL ARTICLE; COMMON COLD; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MALE; OTITIS MEDIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SKIN TEST; SYMPTOM; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VIRUS INFECTION;

EID: 33745212723     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61346-4     Document Type: Article

References (51)

1. Dykewicz MS, Fineman S, Skoner DP, et al; American Academy of Allergy, Asthma and Immunology. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81:478-518.
2. American Academy of Allergy, Asthma and Immunology. Pediatric Asthma: Promoting Best Practice. Guide for Managing Asthma in Children. Milwaukee, WI: American Academy of Allergy, Asthma and Immunology; 1999.
3. von Mutius E. The environmental predictors of allergic disease. J Allergy Clin Immunol. 2000;105:9-19.
4. Gentile DA, Skoner DP. Limitations of human experimental provocation models for investigating the virus-asthma link. In: Skoner DP, ed. Asthma and Respiratory Infections. New York, NY: Marcel-Dekker Inc; 2000.
5. Sporik R, Holgate ST, Platts-Mills TAE, et al. Exposure to house dust mite allergen (Der p I) and the development of asthma in childhood: prospective study. N Engl J Med. 1990; 323:502-507.
6. Martinez FD, Morgan WJ, Wright AL, Holberg Q, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319: 1112-1117.
7. Lemanske RF, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest. 1989;83: 1-10.
8. Doyle WJ, Skoner DP, Seroky J, Fireman P. Effect of experimental influenza infection on nasal response to histamine challenge in allergic and non-allergic subjects. Am J Rhinol. 1993; 7:227-235.
9. Doyle WJ, Skoner DP, Seroky JT, Fireman P, Gwaltney JM. Effect of experimental rhinovirus 39 infection on the nasal response to histamine and cold air challenges in allergic and non-allergic subjects. J Allergy Clin Immunol. 1994;93: 534-542.
10. Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359: 831-834.
11. Bousquet J, Michel FB. In vivo methods for study of allergy skin tests, techniques, and interpretation. In: Middleton E Jr, Reed C, Ellis E, Adkinson NF Jr, Yunginger J, Busse W, eds. Allergy Principles and Practice. Vol 1. 4th ed. St Louis, MO: Mosby-Year Book Inc; 1993:573-594.
12. Hall C. Respiratory syncytial virus: a continuing culprit and conundrum. J Pediatr. 1999;135:S2-S7.
13. Buchman C, Doyle W, Pilcher O, Gentile D, Skoner D. Nasal and otological effects of experimental respiratory syncytial virus infection in adults. Am J Otolaryngol. 2002;23:70-75.
14. Atmar R. Diagnosis of respiratory syncytial disease. New York, NY: American Thoracic Society; 1998:28-33.
15. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 1991;163:693-698.
16. Wright AL, Holberg CJ, Martinez FD, et al. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics. 1994;94:895-901.
17. Nelson H, Oppenheimer J, Buchmeier A, Kordash T, Freshwater L. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol. 1996;97:1193-1201.
18. Gern JE, Busse WW. The effects of rhinovirus infections on allergic airway responses. Am J Respir Crit Care Med. 1995; 152:40-45.
19. Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske RF Jr, Busse WW. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis. 1991;144:1267-1273.
20. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest. 1994;94:2200-2208.
21. Schwarze J, Hamelmann E, Bradley KL, et al. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest. 1997;99:226-233.
22. Korppi M, Kuikka L, Reijonen T, et al. Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. Arch Pediatr Adolesc Med. 1994;148:1079-1084.
23. Skoner DP, Doyle WJ, Tanner EP, Kiss J, Fireman P. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects. Clin Exp Allergy. 1995;25:561-567.
24. Welliver RC, Wong DT, Sun M, Middleton EJ, Vaughan RS, Ogra FL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981;305:841-846.
25. Rabatic S, Gagro A, Lokar-Kolbas R, et al. Increase in CD234-B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus. J Infect Dis. 1997;175:32-37.
26. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95:500-505.
27. Roman M, Calhoun WJ, Hinton K, Avendano L, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med. 1997;156:190-195.
28. Renzi PM, Turgeon JP, Marcotte JE, et al. Reduced interferon-γ production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med. 1999;159:1417-1422.
29. Bendelja K, Gagro A, Bace A, et al. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol. 2000;121:332-338.
30. Schwarze J, Cieslewicz G, Joetham A, et al. Critical roles for interleukin-4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med. 2000; 162:380-386.
31. Alwan WH, Record FM, Openshaw PJM. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J Immunol. 1993;150: 5211-5218.
32. Alwan WH, Kozlowska WJ, Openshaw PJ. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med. 1994;179:81-89.
33. Jackson M, Scott R. Different patterns of cytokine induction in cultures of respiratory syncytial virus specific human T-H cell lines following stimulation with RS virus and RS virus proteins. J Med Virol. 1996;49:161-169.
34. Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy. 1997;27: 284-295.
35. Hagermark O, Hokfelt T, Pernow B. Hare and itch induced by substance P in human skin. J Invest Dermatol. 1978;71: 233-235.
36. Kowalski ML, Sliwinska Kowalska M, Kaliner MA. Neurogenic inflammation, vascular permeability, and mast cells, II: additional evidence indicating that mast cells are not involved in neurogenic inflammation. J Immunol. 1990;145:1214-1221.
37. Piedimonte G, Hoffman J, Husseini W, Hiser W, Nadel J. Effect of neuropeptides released from sensory nerves on blood flow in the rat airway microcirculation. J Appl Physiol. 1992;72: 1563-1570.
38. Iwamoto I, Kimura A, Tanaka M, Tomioka H, Yoshida S. Skin reactivity to substance P, not to neurokinin A, is increased in allergic asthmatics. Int Arch Allergy Appl Immunol. 1990;93: 120-125.
39. King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol. 2001;34:101-107.
40. Piedimonte G, King KA, Holmgren NL, Bertrand PJ, Rodriguez MM, Hirsch RL. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Pediatr Res. 2000;47:351-356.
41. Piedimonte G, Rodriguez MM, King KA, McLean S, Jiang X. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol. 1999;277: L831-L840.
42. Tripp RA, Moore D, Winter J, Anderson LJ. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol. 2000;74: 1614-1622.
43. Noah T, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol. 1993;265:L472-L478.
44. Saito T, Deskin R, Casola A, Haeberle H, et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis. 1997; 175:497-504.
45. Elias JA, Zheng T, Einarsson M, et al. Epithelial interleukin-11: regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem. 1994;269:22261-22268.
46. Noah T, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol. 2000;97:43-49.
47. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest. 1998;101:643-649.
48. Yuta A, Doyle WJ, Gaumond E, et al. Rhinovirus infection induces mucous hypersecretion. Am J Physiol. 1998;274: L1017-L1023.
49. Skoner DP, Gentile DA, Patel A, Doyle JW. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis. 1999;180: 10-14.
50. Gentile D, Doyle W, Whiteside T, et al. Increased interleukin-6 levels in nasal lavages following experimental influenza A viral infection. Clin Diagn Lab Immunol. 1998;5:604-608.
51. Volovitz B, Welliver RC, DeCastro G, et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res. 1988;24:504-507.